Physician profile
Jose P Zevallos
NPI 1346487881
$40,026.21
in general payments reported to CMS, 2019-2025
8 companies · $30K in 2025
The $30K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.90 · 2020: $1,448 · 2022: $5,458 · 2023: $125 · 2024: $2,546 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $33K · Food and Beverage: $494 · Travel and Lodging: $98.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,510.00 |
| Food and Beverage | $494.00 |
| Travel and Lodging | $98.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $25,111.99 | 2025 | |
| Merck Sharp & Dohme LLC | $10,810.00 | 2022-2025 | |
| Medtronic, INC. | $2,422.53 | 2022-2023 | Ligasure |
| Intuitive Surgical, INC. | $1,423.56 | 2020 | |
| Depuy Synthes Sales INC. | $110.06 | 2022 | |
| Integra Lifesciences Corporation | $105.71 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Karl Storz Endoscopy-America | $24.46 | 2020 | |
| Olympus America INC. | $17.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Zevallos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.